In the UK, xenotransplantation is lagging behind the US due to moral and ethical concerns. This is hindering its widespread adoption within the NHS. However, experts are calling for a review of the technology and its potential benefits to help reduce wait times for human organ transplants. By exploring the possibilities offered by xenotransplantation, there may be opportunities to revolutionize organ transplantation and improve outcomes for patients in need.
The first ever human-to-human transplant in 70 years was performed at MGH, a historic milestone with the potential to help millions of patients worldwide. Michael Curtis, CEO of eGenesis, expressed gratitude for the patient’s contribution and the advancement of transplantation science in this groundbreaking surgery. The genetically modified pig that provided the organ for the transplant signifies a new frontier in medicine, showcasing the possibilities of genome engineering for patients suffering from kidney failure.
Dr Nahel Elias, one of the surgeons involved in the transplantation, emphasized the importance of collaboration among multiple teams and specialists at MGH. He credited physicians, surgeons, scientists, anesthesiologists, and nurses for their roles in coordinating the patient’s care, overseeing the surgery, and providing post-operative care. Dr Elias also highlighted